Steve Brozak
Stock Analyst at WBB Securities
(0)
# 5303
Out of 5,332 analysts
13
Total ratings
0.00%
Success rate
-80.49%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRKR Marker Therapeutics | Reiterates: Strong Buy | 13 13 | 1.14 | 996.49% | 1 | Apr 1, 2025 | |
CFRX ContraFect | Upgrades: Strong Buy | 560 | n/a | n/a | 3 | Jun 8, 2022 | |
PRTK Paratek Pharmaceutic... | Upgrades: Strong Buy | 11 | n/a | n/a | 2 | Feb 10, 2022 | |
CDTX Cidara Therapeutics | Upgrades: Strong Buy | n/a | n/a | n/a | 1 | Sep 22, 2021 | |
CWBR CohBar | Upgrades: Buy | 150 | n/a | n/a | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 75 100 | 6.33 | 1479.78% | 1 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Buy | 17000 16000 | 1.9 | 842005.26% | 3 | May 28, 2021 |